News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
729,617 Results
Type
Article (43302)
Company Profile (464)
Press Release (685841)
Multimedia
Podcasts (108)
Webinars (20)
Section
Business (209137)
Career Advice (2035)
Deals (36088)
Drug Delivery (109)
Drug Development (83833)
Employer Resources (174)
FDA (16596)
Job Trends (15169)
News (353728)
Policy (33249)
Tag
Academia (2650)
Accelerated approval (18)
Adcomms (28)
Allergies (119)
Alliances (51112)
ALS (142)
Alzheimer's disease (1616)
Antibody-drug conjugate (ADC) (237)
Approvals (16672)
Artificial intelligence (421)
Autoimmune disease (88)
Automation (29)
Bankruptcy (373)
Best Places to Work (11841)
BIOSECURE Act (20)
Biosimilars (152)
Biotechnology (331)
Bladder cancer (135)
Brain cancer (48)
Breast cancer (496)
Cancer (3917)
Cardiovascular disease (326)
Career advice (1715)
Career pathing (34)
CAR-T (236)
CDC (44)
Cell therapy (638)
Cervical cancer (31)
Clinical research (70034)
Collaboration (1372)
Company closure (4)
Compensation (931)
Complete response letters (51)
COVID-19 (2741)
CRISPR (81)
C-suite (590)
Cystic fibrosis (137)
Data (4688)
Decentralized trials (2)
Denatured (35)
Depression (104)
Diabetes (426)
Diagnostics (6599)
Digital health (34)
Diversity (11)
Diversity, equity & inclusion (45)
Drug discovery (197)
Drug pricing (167)
Drug shortages (29)
Duchenne muscular dystrophy (203)
Earnings (90151)
Editorial (50)
Employer branding (21)
Employer resources (152)
Events (119056)
Executive appointments (956)
FDA (19063)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1243)
Gene editing (171)
Generative AI (32)
Gene therapy (523)
GLP-1 (913)
Government (4702)
Grass and pollen (5)
Guidances (363)
Healthcare (19193)
HIV (44)
Huntington's disease (38)
IgA nephropathy (63)
Immunology and inflammation (224)
Immuno-oncology (19)
Indications (58)
Infectious disease (2968)
Inflammatory bowel disease (181)
Inflation Reduction Act (16)
Influenza (95)
Intellectual property (192)
Interviews (316)
IPO (16899)
IRA (51)
Job creations (3712)
Job search strategy (1441)
Kidney cancer (15)
Labor market (73)
Layoffs (567)
Leadership (29)
Legal (8019)
Liver cancer (87)
Longevity (11)
Lung cancer (564)
Lymphoma (265)
Machine learning (30)
Management (59)
Manufacturing (606)
MASH (139)
Medical device (13774)
Medtech (13797)
Mergers & acquisitions (20075)
Metabolic disorders (1081)
Multiple sclerosis (134)
NASH (19)
Neurodegenerative disease (217)
Neuropsychiatric disorders (58)
Neuroscience (2626)
NextGen: Class of 2025 (6759)
Non-profit (4564)
Now hiring (59)
Obesity (515)
Opinion (265)
Ovarian cancer (137)
Pain (157)
Pancreatic cancer (171)
Parkinson's disease (236)
Partnered (28)
Patents (408)
Patient recruitment (321)
Peanut (53)
People (59669)
Pharmaceutical (86)
Pharmacy benefit managers (25)
Phase I (21992)
Phase II (30877)
Phase III (22855)
Pipeline (2744)
Policy (260)
Postmarket research (2602)
Preclinical (9447)
Press Release (67)
Prostate cancer (198)
Psychedelics (50)
Radiopharmaceuticals (275)
Rare diseases (650)
Real estate (6048)
Recruiting (70)
Regulatory (23997)
Reports (51)
Research institute (2448)
Resumes & cover letters (354)
Rett syndrome (15)
RNA editing (15)
RSV (67)
Schizophrenia (134)
Series A (207)
Series B (157)
Service/supplier (11)
Sickle cell disease (80)
Special edition (25)
Spinal muscular atrophy (154)
Sponsored (36)
Startups (3790)
State (2)
Stomach cancer (15)
Supply chain (94)
Tariffs (81)
The Weekly (71)
Vaccines (933)
Venture capital (65)
Weight loss (340)
Women's health (57)
Worklife (18)
Date
Today (134)
Last 7 days (666)
Last 30 days (2709)
Last 365 days (31336)
2025 (25770)
2024 (36300)
2023 (41015)
2022 (52279)
2021 (56767)
2020 (54920)
2019 (47422)
2018 (35700)
2017 (33033)
2016 (32350)
2015 (38405)
2014 (32191)
2013 (27121)
2012 (29229)
2011 (29872)
2010 (28000)
Location
Africa (748)
Alabama (77)
Alaska (7)
Arizona (278)
Arkansas (14)
Asia (40148)
Australia (6674)
California (9453)
Canada (2858)
China (887)
Colorado (396)
Connecticut (416)
Delaware (264)
Europe (87980)
Florida (1393)
Georgia (304)
Hawaii (2)
Idaho (60)
Illinois (737)
India (48)
Indiana (454)
Iowa (20)
Japan (322)
Kansas (122)
Kentucky (36)
Louisiana (19)
Maine (68)
Maryland (1235)
Massachusetts (6998)
Michigan (284)
Minnesota (546)
Mississippi (4)
Missouri (111)
Montana (31)
Nebraska (25)
Nevada (103)
New Hampshire (77)
New Jersey (2608)
New Mexico (30)
New York (2548)
North Carolina (1328)
North Dakota (9)
Northern California (4373)
Ohio (286)
Oklahoma (20)
Oregon (41)
Pennsylvania (1978)
Puerto Rico (19)
Rhode Island (44)
South America (1115)
South Carolina (48)
South Dakota (1)
Southern California (3626)
Tennessee (148)
Texas (1460)
United States (34380)
Utah (277)
Virginia (226)
Washington D.C. (78)
Washington State (800)
West Virginia (4)
Wisconsin (82)
Wyoming (1)
729,617 Results for "fate therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fate Therapeutics Expands Leadership Team with Appointment of Kamal Adawi as Chief Financial Officer
October 15, 2025
·
7 min read
Press Releases
Fate Therapeutics to Present at Upcoming September 2025 Investor Conferences
August 25, 2025
·
1 min read
Press Releases
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - October 2, 2025
October 3, 2025
·
2 min read
Press Releases
Fate Therapeutics Reports Second Quarter 2025 Financial Results and Business Updates
August 12, 2025
·
17 min read
Press Releases
Fate Therapeutics Presents New Clinical Data at ACR Convergence 2025 Demonstrating Immune Remodeling and Durable Responses in Patients with Systemic Lupus Erythematosus Treated with FT819 Off-the-Shelf CAR T-Cell Therapy
October 27, 2025
·
13 min read
Press Releases
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - September 3, 2025
September 4, 2025
·
2 min read
Press Releases
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - August 5, 2025
August 6, 2025
·
2 min read
Opinion
Fate of FDA’s Laboratory-Developed Testing Final Rule Hints at
Chevron
Overturn’s Ramifications
In one of the first demonstrations of the impact of last year’s Loper Supreme Court decision on challenges to agency authority, a judge ruled that the FDA does not have authority to regulate tests developed by clinical laboratories.
September 29, 2025
·
4 min read
·
Megan Robertson
Biotech Beach
Fate Therapeutics to Present at 2024 Jefferies Global Healthcare Conference
Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE) today announced that the Company will present at the 2024 Jefferies Global Healthcare Conference on Wednesday, June 5, 2024 at 3:00 PM ET in New York, New York.
May 29, 2024
·
1 min read
Press Releases
Fate Therapeutics Appoints Matthew Abernethy, M.B.A., to its Board of Directors
May 30, 2025
·
5 min read
1 of 72,962
Next
